Possible side effects are typically mild and temporary, including injection site reactions, occasional headaches, nausea, or lightheadedness, and a metallic taste in the mouth
This was mediated through disruption of microbiota-gut-brain axis homeostasis, specifically manifested as reduced production of serotonin (5-HT) in the gut, leading to lower levels transported to the brain via the bloodstream, ultimately contributing to neurobehavioral deficits
25 l aliquots of samples were snap-frozen and stored for a protein concentration measurement
Commonly Reported Side Effects The most frequently observed adverse events in the Phase 2 trial were gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation